GE HealthCare introduces elevated Venue point of care ultrasound solutions and new tablet-based Venue Sprint
GE HealthCare Technologies Inc. (GEHC)
Company Research
Source: Business Wire
Unveiling Venue Sprint™, the latest Venue family solution offering maximum portability and advanced capabilities for high-quality scanning and support at the point of careVenue family enhancements include advanced software and wireless flexibility with the integration of Vscan Air™ probes CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced the launch of enhanced Venue ultrasound systems and a new solution setting the pace of point-of-care ultrasound (POCUS): Venue Sprint. The Venue Sprint is a new ultrasound device designed for maximum portability that combines the powerful, familiar Venue software and AI-enabled tools, uncompromised image quality, and wireless probe capability with Vscan Air handheld ultrasound systems. Other Venue family ultrasound systems will also now offer wireless probe connectivity, supplementary advanced clinical tools and the latest ViewPoint™ 6 updates for increased efficiency and optimized workflow.POCUS continues to grow as a valuable
Show less
Read more
Impact Snapshot
Event Time:
GEHC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GEHC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GEHC alerts
High impacting GE HealthCare Technologies Inc. news events
Weekly update
A roundup of the hottest topics
GEHC
News
- GE HealthCare announces FDA approval of Flyrcado (flurpiridaz F 18) injection PET radiotracer for enhanced diagnosis of coronary artery diseaseBusiness Wire
- GE HealthCare Showcases the Latest AI-enhanced Radiation Therapy Solutions at ASTRO 2024Business Wire
- GE HealthCare Technologies Inc. (NASDAQ: GEHC) was downgraded by analysts at UBS Group AG from a "neutral" rating to a "sell" rating. They now have a $74.00 price target on the stock, down previously from $84.00.MarketBeat
- GE HealthCare announces cash dividend for third quarter of 2024 [Yahoo! Finance]Yahoo! Finance
- GE HealthCare announces cash dividend for third quarter of 2024Business Wire